Funding
← Back to your selection

Kinnevik

Activity from announced rounds

Activity in this selectionUnited States
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$351M
2 disclosed · full round size, not this investor’s share

By stage

Series C+1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Anterior

Anterior helps health insurers and delegated care organizations apply clinical AI to prior authorization, utilization management and other payer workflows.

$40MUndisclosed
Role not disclosed